Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diversified Biotech Holdings Corporation was a New York-based investment and holding company founded in 1999 by Scott L. Mathis. The firm specialized in the biotechnology sector, operating through subsidiaries such as InvestBio, Inc., which provided research and investment opportunities, and InvestPrivate, Inc., a boutique brokerage firm. The company aimed to provide accredited investors with access to specialized biotech financial products, including venture capital and hedge funds. However, the company became the subject of significant regulatory actions by the NASD and SEC in the mid-2000s due to fraudulent self-offerings and undisclosed compensation. The entity eventually ceased its primary operations, and its founder transitioned to leading Gaucho Group Holdings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diversified Biotech Holdings.